Welcome to our dedicated page for BKHU news (Ticker: BKHU), a resource for investors and traders seeking the latest updates and insights on BKHU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BKHU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BKHU's position in the market.
Bakhu Holdings Corp. has appointed Teddy C. Scott as its new CEO and Chair of the Board, effective September 20, 2021. With over 20 years in biotechnology and cannabis, Scott aims to shift the company's focus from R&D to commercialization of its cell replication technology. His immediate goals include exploring strategic transactions, expanding the management team, and enhancing the intellectual property portfolio. Scott previously served as CEO of PharmaCann and Ethos. Former CEO Thomas K. Emmitt has resigned to pursue other opportunities.
